These milieu effects align with the contemporary phenotype measured in cirrhosis: reduced aggregation to multiple agonists, reduced dense-granule ATP release, and suppressed activation (reduced P-selectin/CD62P expression and PAC-1 binding) as measured by flow cytometry (81). Here, SELP is linked to Cirrhosis.